Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Josef Kletzmayr"'
Autor:
Oliver Königsbrügge, Florian Posch, Marlies Antlanger, Josef Kovarik, Renate Klauser-Braun, Josef Kletzmayr, Sabine Schmaldienst, Martin Auinger, Günther Zuntner, Matthias Lorenz, Ella Grilz, Gerald Stampfel, Stefan Steiner, Ingrid Pabinger, Marcus Säemann, Cihan Ay
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169400 (2017)
Atrial fibrillation (AF) adds significant risk of stroke and thromboembolism in patients on hemodialysis (HD). The aim of this study was to investigate the prevalence of AF in a population-based cohort of HD patients and practice patterns of antithro
Externí odkaz:
https://doaj.org/article/2eb0db03bbec45d2bc620d4fe06c6920
Autor:
Oliver Königsbrügge, Manfred Hecking, Marcus D. Säemann, Martin Auinger, Renate Klauser-Braun, Matthias Lorenz, Sabine Schmaldienst, Jolanta M. Siller-Matula, Brigitte Enzenberger, Cihan Ay, Ingrid Pabinger, Susanne Tabernig, Manfred Eigner, Josef Kletzmayr
Publikováno v:
Atherosclerosis. 298:1-6
Background and aims Cardiovascular disease (CVD) is common in patients with end-stage renal disease (ESRD) on hemodialysis (HD). However, antithrombotic therapy to prevent CVD increases the risk of bleeding. We aimed to investigate the prevalence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ff78ff01188954492acba2ff79a8df6
https://doi.org/10.1016/j.atherosclerosis.2020.02.011
https://doi.org/10.1016/j.atherosclerosis.2020.02.011
Autor:
Josef Kletzmayr, Oliver Königsbrügge, Martin Auinger, Renate Klauser-Braun, Aljoscha Beyer, Hannah Meisel, Matthias Lorenz, Irene Lang, Ingrid Pabinger, Sabine Schmaldienst, Manfred Hecking, Marcus D. Säemann, Cihan Ay, Wolfgang C. Winkelmayer
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 19(12)
Background Evidence supporting the use of anticoagulation for the prevention of stroke and thromboembolism in patients with kidney failure on hemodialysis (HD) and atrial fibrillation (AF) is limited. We prospectively assessed the incidences of strok
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50aefdfd47f23444d2651d4f93b338b6
https://pubmed.ncbi.nlm.nih.gov/34418291
https://pubmed.ncbi.nlm.nih.gov/34418291
Autor:
Daniel W. Coyne, Dhananjai Agarwal, Georg Wirtz, Philip A. Kalra, Lars L. Thomsen, Sunil Bhandari, Josef Kletzmayr, Sanjiv Saxena
Publikováno v:
Nephrology Dialysis Transplantation
Kalra, P A, Bhandari, S, Saxena, S, Agarwal, D, Wirtz, G, Kletzmayr, J, Thomsen, L L & Coyne, D W 2016, ' A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia ', Nephrology, Dialysis, Transplantation, vol. 31, no. 4, pp. 646-655 . https://doi.org/10.1093/ndt/gfv293
Kalra, P A, Bhandari, S, Saxena, S, Agarwal, D, Wirtz, G, Kletzmayr, J, Thomsen, L L & Coyne, D W 2016, ' A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia ', Nephrology, Dialysis, Transplantation, vol. 31, no. 4, pp. 646-655 . https://doi.org/10.1093/ndt/gfv293
BackgroundIron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15649cddf05091bd4f630e75cfb82c2f
http://europepmc.org/articles/PMC4805129
http://europepmc.org/articles/PMC4805129
Autor:
Sabine Schmaldienst, Marcus D. Säemann, Ella Grilz, Martin Auinger, Matthias Lorenz, Marlies Antlanger, Cihan Ay, Oliver Königsbrügge, Renate Klauser-Braun, Josef Kletzmayr, Florian Posch, Ingrid Pabinger
Publikováno v:
Thrombosis research. 158
Background Patients with end-stage renal disease (ESRD) on maintenance hemodialysis (HD) are at risk for occurrence of vascular access thrombosis and venous thromboembolism (VTE). Understanding the extent of these complications and identifying risk f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c75dc23bc1a308831c5927fea4eba7d
https://pubmed.ncbi.nlm.nih.gov/28843824
https://pubmed.ncbi.nlm.nih.gov/28843824
Autor:
Guerkan Sengoelge, Martin Brunner, Walter H. Hörl, Josef Kletzmayr, Harald Herkner, Wolfgang Winnicki, Gere Sunder-Plassmann, Anna Prehslauer
Publikováno v:
European Journal of Clinical Investigation. 42:1087-1093
Background There is ongoing controversy whether angiotensin-converting enzyme inhibitors (ACE-I) contribute to anaemia by causing hyporesponsiveness to erythropoiesis-stimulating agents (ESA). However, it is unknown whether or not plasma levels or ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f24858c1af91a754b8c2270d2eb4862
https://doi.org/10.1111/j.1365-2362.2012.02699.x
https://doi.org/10.1111/j.1365-2362.2012.02699.x
Autor:
Robert Thimme, Michael Roggendorf, A. Haberstroh, Josef Kletzmayr, Christoph Neumann-Haefelin, Renate Klauser-Braun, Stefan Ross, Thomas F. Baumert, Heidemarie Holzmann, Joerg Timm, Judith H. Aberle, Lukas Weseslindtner, Sergei Viazov
Publikováno v:
Journal of Hepatology. 50:693-704
Background/Aims While the adaptive immune response is crucial for spontaneous resolution of acute hepatitis C virus (HCV) infection, it also constitutes the driving force for viral escape. For acutely HCV-infected dialysis patients, little is known a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8621a4c3c49fea7cc6658e2bc2b9770d
https://doi.org/10.1016/j.jhep.2008.11.023
https://doi.org/10.1016/j.jhep.2008.11.023
Autor:
Alison C. Agu, Reinhold Hofbauer, Josef Kletzmayr, Alzbeta Godarova, Alfred Lohninger, Elke Litzlbauer
Publikováno v:
Monatshefte für Chemie - Chemical Monthly. 136:1509-1521
We analysed the effects of carnitine substitution on carnitine acyltransferases in Rat1-cells, mouse NIH3T3, and human MRC5 fibroblasts serving as reporter cells. For cultivation we used human sera isolated from well-defined conditions of carnitine d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfbcb21a79979a482cac63e90b2c7154
https://doi.org/10.1007/s00706-005-0338-3
https://doi.org/10.1007/s00706-005-0338-3
Autor:
Josef Kletzmayr, Wilfred Druml, Matthias Lorenz, Bettina Haidbauer, Heinz Regele, Georg A. Böhmig, Martin Schillinger, Kurt Derfler
Publikováno v:
Transplantation. 79:696-701
BACKGROUND Kidney transplant recipients with a current positive complement-dependent cytotoxicity crossmatch (CDCXM) are at high risk for hyperacute rejection and graft loss. Immunoadsorption (IA) represents an efficient strategy to remove donor-spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::178781ebb6a78f0cb5db54e3dd3f0082
https://doi.org/10.1097/01.tp.0000148732.26761.fa
https://doi.org/10.1097/01.tp.0000148732.26761.fa
Autor:
Josef Kletzmayr, Georg A. Böhmig, Markus Exner, Markus Wahrmann, Martin Schillinger, Gerd R. Silberhumer, Susanne Rasoul-Rockenschaub, Matthias Lorenz, Heinz Regele, Walter H. Hörl
Publikováno v:
Transplantation. 78:447-452
Background. Capillary deposition of the complement split product C4d has turned out to be a valuable marker of antibody-mediated rejection. The impact of pre- and posttransplant variables including particular immunosuppressive regimens on the frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba74a65b0d726aaa02e0f04e5ee4241e
https://doi.org/10.1097/01.tp.0000128344.94808.03
https://doi.org/10.1097/01.tp.0000128344.94808.03